Patients with active cancer who developed a blood clot, or venous thromboembolism (VTE), and were treated with blood-thinning ...

Blood tests that detect early cancer are coming to market. Could they lead to earlier diagnosis and treatment?

A study shows reduced-dose apixaban effectively prevents recurrent blood clots in cancer patients, lowering bleeding risks ...

Results show noninferiority to a full dose in preventing a recurrence of blood clots and an advantage when it comes to ...